TABLE 1 –
Factor | Overall (N=381) | PCDT Arm (N=190) | Control Arm (N=191) | P Value |
---|---|---|---|---|
Age (years) | 51.0 [39.0,62.0] | 51.0 [38.0,62.0] | 52.0 [42.0,61.0] | 0.65 a |
Sex | 0.72 b | |||
Male | 203 (53.3%) | 103 (54.2%) | 100 (52.4%) | |
Female | 178 (46.7%) | 87 (45.8%) | 91 (47.6%) | |
Race | 0.28 b | |||
White | 296 (77.7%) | 152 (80.0%) | 144 (75.4%) | |
Other | 85 (22.3%) | 38 (20.0%) | 47 (24.6%) | |
Ethnicity | 0.34 b | |||
Not Hispanic or Latino | 352 (92.4%) | 178 (93.7%) | 174 (91.1%) | |
Hispanic or Latino | 29 (7.6%) | 12 (6.3%) | 17 (8.9%) | |
BMI (kg/m2) | 30.8 [27.0,36.7] | 30.9 [27.6,36.9] | 30.8 [25.5,36.4] | 0.26 a |
Index Leg | 0.78 b | |||
Left | 244 (64.0%) | 123 (64.7%) | 121 (63.4%) | |
Right | 137 (36.0%) | 67 (35.3%) | 70 (36.6%) | |
Previous DVT | 0.64 b | |||
No | 295 (77.4%) | 149 (78.4%) | 146 (76.4%) | |
Yes | 86 (22.6%) | 41 (21.6%) | 45 (23.6%) | |
Provoked DVT | 0.42 b | |||
No | 319 (83.7%) | 162 (85.3%) | 157 (82.2%) | |
Yes | 62 (16.3%) | 28 (14.7%) | 34 (17.8%) | |
Hypertension | 0.23 b | |||
No | 226 (59.3%) | 107 (56.3%) | 119 (62.3%) | |
Yes | 155 (40.7%) | 83 (43.7%) | 72 (37.7%) | |
Diabetes | 0.41 b | |||
No | 311 (81.6%) | 152 (80.0%) | 159 (83.2%) | |
Yes | 70 (18.4%) | 38 (20.0%) | 32 (16.8%) | |
High Cholesterol | 0.55 b | |||
No | 270 (70.9%) | 132 (69.5%) | 138 (72.3%) | |
Yes | 111 (29.1%) | 58 (30.5%) | 53 (27.7%) | |
PV Compressible | 0.89 b | |||
No | 273 (80.1%) | 135 (80.4%) | 138 (79.8%) | |
Yes | 68 (19.9%) | 33 (19.6%) | 35 (20.2%) | |
Total Villalta Score | 10.0 [6.0,14.0] | 10.0 [7.0,14.0] | 9.6 [6.0,14.0] | 0.23a |
Symptom Duration (days) | 6.0 [3.0,9.0] | 6.0 [3.0,9.0] | 6.0 [3.0,9.0] | 0.42 a |
PCDT = pharmacomechanical catheter-directed thrombolysis
DVT = deep vein thrombosis
PV = popliteal vein
BMI = body-mass index
= Kruskal-Wallis test
= Pearson’s Chi-square test